throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`WEATHERFORD INTERNATIONAL, LLC; WEATHERFORD/LAMB,
`INC.; WEATHERFORD US, LP; and WEATHERFORD ARTIFICIAL
`LIFT SYSTEMS, LLC,
`Petitioners
`
`v.
`
`PACKERS PLUS ENERGY SERVICES INC.,
`Patent Owner
`
`___________________
`
`Case IPR2016-01509
`Patent 7,861,774
`___________________
`
`
`
`EXCLUSIVE LICENSEE RAPID COMPLETIONS LLC’S
`RESPONSE TO PETITIONERS’ MOTION TO EXCLUDE
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`“The party moving to exclude evidence bears the burden of proving that it is
`
`entitled to the relief requested—namely, that the material sought to be excluded is
`
`inadmissible under the Federal Rules of Evidence.” Petroleum Geo-Services Inc.
`
`v. Ion Geophysical Corp., IPR2014-00688, Paper 101 at 53 (PTAB Dec. 15, 2015)
`
`(citing 37 C.F.R. §§ 42.20(c), 42.62(a)). Petitioners’ motion appears to disregard
`
`this requirement as it seeks exclusion of dozens of exhibits by merely referring to a
`
`portion of the exhibit and stating a rule of evidence. Moreover, with regard to
`
`several objections, including to the testimony from Mr. McGowen, Dr. Daneshy,
`
`and representatives of Baker Hughes and Packers Plus, Petitioners fail to recognize
`
`the applicable procedures and evidentiary rules for submitting this type of evidence
`
`in IPRs. In short, Weatherford has failed to meet its burden, and its arguments
`
`relate at most to weight not admissibility.
`
`Objections to McGowen Testimony
`
`Petitioners sole basis for objecting to Mr. McGowen’s testimony is that it is
`
`based on undisclosed information controlled by Baker Hughes. This objection is
`
`untimely as it was raised for the first time well after Rapid Completions served
`
`exhibits 2051 and 2081. See Paper 40. Regardless, unlike in district court, this
`
`objection goes only to weight not admissibility. Moreover, even if Weatherford
`
`had raised a timely, legally cognizable objection, the only portion of Mr.
`
`McGowen’s testimony that is actually based on confidential Baker Hughes
`
`
`
`1
`
`

`

`information is a specific calculation of Baker Hughes’ revenue from sales of its
`
`FracPoint service. This calculation is redacted in Exhibit 2051 and it is not even
`
`included in Exhibit 2081. Thus, Petitioners’ objection is moot.
`
`Factual Background
`
`In response to Baker Hughes’ first set of IPRs, Mr. McGowen compiled a
`
`database of FracPoint jobs performed by Baker Hughes in the United States. He
`
`used that database to estimate the amount of revenue that Baker Hughes had earned
`
`from practicing the claimed invention during the limited damages window at issue
`
`in litigation. This database contained confidential information produced by Baker
`
`Hughes in the parties’ underlying litigation. Ex. 2051 at 46. Baker Hughes
`
`consented to use of the information in its IPRs, but it did not authorize Rapid
`
`Completions to share that information with Weatherford. Ex. 2081 at 25. Thus,
`
`Rapid Completions redacted that calculation when it filed the McGowen
`
`declaration in the present proceeding. The remainder of the declaration is based on
`
`publicly available information to which Weatherford has not objected.
`
`
`
`Because commercial success is relevant to the present proceeding, and Baker
`
`Hughes has refused to allow Rapid Completions to share its confidential
`
`information with Weatherford, Mr. McGowen prepared a separate revenue
`
`calculation for this proceeding—he estimated Baker Hughes’ revenue based only
`
`on publicly available information. Ex. 2081 at 27. Respondent relied on that
`
`
`
`2
`
`

`

`testimony in this proceeding to provide the Board with the relevant information
`
`regarding commercial success without the need for motion practice before the
`
`Board or before the district court to seek relief from the protective order. As it
`
`turned out though, after Rapid Completions served its patent owner response,
`
`Weatherford did not object to Mr. McGowen’s public revenue calculation in
`
`exhibit 2081, or the fact that his confidential calculation was redacted from exhibit
`
`2051. Paper 34. Thus, the issue appeared to be moot.
`
`
`
`Over a month later, during the deposition of Mr. McGowen, Weatherford
`
`asked Mr. McGowen about facts he was aware of. He answered truthfully that he
`
`was also aware of confidential Baker Hughes data. Ex. 1038 at 161:15-163:25. Of
`
`course, it is not as if Weatherford learned that Mr. McGowen had access to this
`
`information for the first time in his deposition. Exhibit 2051 contains a redaction
`
`for this very reason, and exhibit 2081 states: “In my original declaration, I also
`
`analyzed the success of Baker Hughes’s FracPoint system. Because this analysis
`
`was based in part on confidential Baker Hughes information, I understand that
`
`Baker Hughes has objected to sharing that information with Weatherford.
`
`Nonetheless, public information provides a good indication of the success of Baker
`
`Hughes’s system.” Ex. 2081 at 25.
`
`Even if Weatherford had learned of this issue for the first time in the
`
`deposition, it expressly chose not to raise an objection during the deposition as
`
`
`
`3
`
`

`

`required by 37 CFR 42.64(a) (“An objection to the admissibility of deposition
`
`evidence must be made during the deposition.”).1 See Ex. 1038 at 164:1-3
`
`(Weatherford counsel: “Okay. So, I mean, we can take this up later, but here an
`
`expert is relying on information that we can't cross-examine him on.”). Even after
`
`the deposition ended, Weatherford provided no indication that it intended to raise
`
`an objection on this basis until the day after it served its reply—months after it was
`
`served with Mr. McGowen’s declaration, and weeks after it took his deposition.
`
`This is too late. Cf. 37 CFR 42.64(b) (“Once a trial has been instituted, any
`
`objection must be filed within five business days of service of evidence to which
`
`the objection is directed.”).
`
`Once Weatherford finally did provide an objection, Rapid Completions
`
`emailed litigation and IPR counsel for Baker Hughes and Weatherford to remind
`
`them that the litigation protective order states:
`
`DESIGNATED MATERIAL produced by one defendant shall not be
`disclosed to counsel for any other defendant without written consent of
`the producing party. Defendants will not object to the admission of
`evidence based on the grounds that Plaintiffs could not share the
`documents with a Defendant or Defendants’ witness, although all other
`objections to admissibility and/or relevance are reserved. Nothing in
`this section shall relieve Plaintiff from timely disclosing and/or
`producing evidence on which they intend to rely. The Defendants will
`
`
`1 37 CFR 42.64(a) is not strictly applicable because Weatherford is only
`objecting to Mr. McGowen’s declaration. Weatherford submitted Mr. McGowen’s
`deposition testimony into evidence without objection.
`
`
`
`4
`
`

`

`work together to obtain access to evidence from other Defendants
`that may be identified by Rapid Completions.”
`
`Case 6:15-cv-724, Dkt. 248 at ¶ 6 (emphasis added). While this provision is not
`
`directly applicable in an IPR, the fact that a mechanism exists for resolving
`
`precisely this sort of dispute shows that, while Rapid Completions cannot provide
`
`confidential Baker Hughes information to Weatherford, Weatherford need only ask
`
`for the information if it really needed it. Weatherford responded that it would not
`
`attempt to obtain the information because it had already been prejudiced by served
`
`its reply without the information. Of course, Weatherford manufactured that
`
`prejudice by withholding its objection until after it served its reply—when it could
`
`claim that any attempt to cure the alleged prejudice is futile.
`
`Argument
`
`According to Weatherford, it was unable to adequately cross examine Mr.
`
`McGowen because Rapid Completions failed to produce confidential Baker
`
`Hughes information. This is wrong. Weatherford knew that Mr. McGowen had
`
`access to that information well before his deposition, and it also knew that his more
`
`recent declaration (Ex. 2081) did not rely on that information. Weatherford
`
`decided to lay behind the log and only disclose its objection to that fact after the
`
`objection deadline and after Mr. McGowen’s deposition. Had it raised this
`
`objection earlier, the parties could have presented this dispute to the Board or the
`
`district court for resolution, or Weatherford could have simply obtained the
`
`
`
`5
`
`

`

`information from Baker Hughes—something that it could do but Rapid
`
`Completions could not. Its decision to withhold its objection until after it could
`
`claim to have been prejudiced by a lack of adequate cross examination is pure
`
`gamesmanship. Accordingly, it should be overruled as untimely.
`
`In addition, even if its objection were timely, Weatherford has failed to
`
`provide a legally cognizable theory for exclusion of evidence. Its objection is
`
`based on Trial Practice Guide § II(A)(4). But this provision states: “Opinions
`
`expressed without disclosing the underlying facts or data may be given little or no
`
`weight.” See also 37 C.F.R. § 42.65(a) (same). Unlike in district court, these
`
`provisions confirm that, in an IPR, an expert’s failure to disclose underlying facts
`
`or data is an issue of weight not admissibility. Corning Inc. v. DSM IP Assets BV,
`
`IPR2013-0048, Paper 94 at 74 (PTAB May 9, 2014) (“Whether a witness’s
`
`testimony fails to include underlying facts or data on which an opinion is based
`
`goes to the weight that should be accorded the testimony, and not its
`
`admissibility.”). Thus, even if Rapid Completions were required to violate a
`
`district court protective order by producing confidential information from Baker
`
`Hughes to its joint defense partner Weatherford, the fact that it abided by the
`
`protective order would go to the weight afforded Mr. McGowen’s testimony, not
`
`
`
`6
`
`

`

`its admissibility.2 If Weatherford is entitled to any relief, it is an order from the
`
`Board compelling Baker Hughes to produce its sales information to Weatherford’s
`
`outside counsel.
`
`
`
`Of course, such an order is not necessary because Rapid Completions
`
`specifically developed evidence to avoid a protective order dispute. Contrary to
`
`Weatherford’s assertion that “[Mr.] McGowen offered no evidence in response to
`
`questions about the bases for his commercial success opinions,” Mot. at 6, Exhibits
`
`2051 (e.g., pages 41-50) and 2081 (e.g., pages 25-30) contain substantial evidence
`
`of commercial success without disclosing confidential Baker Hughes information.
`
`Indeed, objected to section 11.2 of exhibit 2081 begins: “In my original
`
`declaration, I also analyzed the success of Baker Hughes’s FracPoint system.
`
`Because this analysis was based in part on confidential Baker Hughes information,
`
`I understand that Baker Hughes has objected to sharing that information with
`
`Weatherford. Nonetheless, public information provides a good indication of the
`
`success of Baker Hughes’s system.” The Board may admit these exhibits without
`
`admitting Mr. McGowen’s confidential revenue calculation because it is already
`
`
`2 The fact that Weatherford did not have Mr. McGowen’s confidential
`revenue calculation before his deposition should not cause the Board to discount
`the weight afforded his testimony because Weatherford’s own gamesmanship is
`responsible for any prejudice it suffered. Moreover, Mr. McGowen provided his
`public calculation to avoid any such prejudice or discounting of his opinions.
`
`
`
`7
`
`

`

`redacted from exhibit 2051. Thus, this objection is also moot.
`
`Authenticity, Relevance, and Timeliness Objections
`
`
`
`Petitioners object to exhibits 2004-2010, 2012, and 2020 as inauthentic
`
`because they were submitted with the preliminary response, but authentication
`
`declarations for the exhibits (exhibits 2083 and 2091) were submitted with the
`
`formal patent owner response. However, this is the proper procedure for
`
`submitting this type of evidence. See Nuvasive, Inc. v. Warsaw Orthopedic, Inc.,
`
`IPR2013-00206, Paper 22 at 3 (PTAB Oct. 15, 2013) (ruling that a patent owner
`
`served with an objection to preliminary response evidence need not provide new
`
`evidence to rebut the objection until the patent owner response deadline). Even if
`
`Petitioners’ timeliness objection were technically accurate—which it is not—
`
`Respondent would have good cause to submit exhibits 2083 and 2091 after the
`
`alleged deadline. As explained in Nuvasive, a petitioner suffers no prejudice from
`
`receiving new testimonial evidence with a patent owner response, and respondent
`
`should not be faulted for following the procedure outlined in existing precedent.
`
`Because Petitioners do not dispute that exhibits 2083 and 2091 authenticate these
`
`exhibits, this objection fails.
`
`
`
`Exhibit 2014 is a portion of a book written by Ali Daneshy. He testified that
`
`it is authentic. Ex. 2016 at 15:1-21. Moreover, all of exhibits 2004-2012, 2014
`
`and 2020 are authentic under Rule 901(b)(4) and 902(6). The requirement of
`
`
`
`8
`
`

`

`authenticity requires only that a proponent demonstrate that a document is what the
`
`proponent claims it to be. Respondent merely asserts that these exhibits are
`
`industry publications, and the distinctive markings of each document establish that
`
`to be the case. See, e.g., Ciampi v. City of Palo Alto, 790 F. Supp. 2d 1077, 1091
`
`(N.D. Cal. 2011) (admitting Internet printouts that “contain sufficient indicia of
`
`authenticity, including distinctive newspaper and website designs, dates of
`
`publication, page numbers, and web addresses”); Liberty Mutual Ins. Co. v.
`
`Progressive Casualty Ins. Co., CBM2012-00010, Paper 59 at 37 (PTAB Feb. 24,
`
`2014) (admitting various articles under Rule 902(6)). The exhibits are also
`
`admissible under Rule 703 to the extent they have been relied upon by Mr.
`
`McGowen. See Ex. 2051 at 48-50.
`
`
`
`Petitioners object to exhibits 2004-2012, 2014, 2020, 2045-2047, 2054,
`
`2061, and 2086-2089 as irrelevant because they are insufficiently tied to the
`
`claimed invention. In particular, Petitioners note that various of these exhibits fail
`
`to “mention[] the long list of steps recited in claim 1 of the ’774 patent.” Mot. at 8.
`
`But the fact that various industry publications and news footage fails to analyze
`
`specific claim language does not mean that this evidence is irrelevant to the issue
`
`of praise for the invention. Indeed, it is an artifact of the fact that Mr. Themig
`
`invented something new to the industry. See Ex. 2013 (describing open hole multi-
`
`stage fracturing as having been introduced in 2001, but not having “a unique
`
`
`
`9
`
`

`

`industry accepted name”). These exhibits nonetheless describe the operation of
`
`open hole multi-stage fracturing, which, as explained by Mr. McGowen, fits the
`
`requirements of the claim language. See, e.g., Ex. 2051 at 47-50, 64-77
`
`(explaining that StackFRAC and FracPoint “simply are the invention disclosed
`
`and claimed in the invention”).
`
`While Petitioners may disagree that these exhibits specifically praise the
`
`invention covered by claim 1, they certainly meet the minimum threshold for
`
`relevance under Rule 401. If an article praises StackFRAC without explaining
`
`why it is praising StackFRAC, it may be entitled to less weight than, for example,
`
`exhibit 2045 which states: “StackFRAC was the first ball drop system created for
`
`open hole horizontal wells” that is “partly responsible for creating access to vast
`
`reservoirs of oil and natural gas in North America that were previously considered
`
`uneconomic to produce.” Nonetheless, all of these exhibits are at least probative of
`
`praise for the invention.
`
`Hearsay Objections
`
`Ghiselin Study. Exhibit 2010 is a market report on market share of open
`
`hole multistage systems versus plug and perf systems. Petitioners object to the
`
`report as hearsay. However, this report falls under hearsay exceptions (17) and
`
`(18). It is a market report relied upon by an expert in the field—Mr. McGowen.
`
`At any rate, even if this market share information does not fall under those
`
`
`
`10
`
`

`

`exceptions, the exhibit is still admissible for a purpose other than proving the truth
`
`of the matter asserted. Namely, that persons in the field expected the patented
`
`technology to have had a significant market share. Even if the actual market share
`
`for this technology differed from the reported amount, the fact that practitioners
`
`expected the technology to be increasingly competitive against traditional plug and
`
`perf demonstrates that the technology has received praise and success.
`
`Moreover, even if the Board deems this exhibit inadmissible for any reason,
`
`it may still be considered under Rule 703. See, e.g., SK Innovation Co. v. Celgard
`
`LLC, IPR2014-00680, Paper 57 at 28 (PTAB Sept. 25, 2015) (admitting evidence
`
`of commercial success under Rule 703). Respondent’s expert Mr. McGowen
`
`offered testimony based on this exhibit. See Ex. 2081 at 25; Ex. 2051 at 46.
`
`Petitioners have not moved to exclude this testimony, and thus the substantive
`
`information from the exhibit has already been admitted. Under Rule 703, the
`
`evidence underlying that testimony is also admissible subject only to concerns
`
`related to jury trials that are inapplicable in IPRs.3
`
`
`3 In district court, Rule 703, requires a proponent to show that any otherwise
`inadmissible evidence underlying an expert’s testimony has “probative value in
`helping the jury evaluate the opinion [that] substantially outweighs [its] prejudicial
`effect.” This provision is inapplicable in IPRs. 37 C.F.R. § 42.62(b) (portions of
`the Federal Rules of Evidence relating to juries do not apply). Regardless, this
`exhibit is probative of commercial success as it corroborates the testimony of Mr.
`McGowen and the other evidence relied upon by Mr. McGowen. Petitioners
`identify no prejudicial effect from admitting it, and it is difficult to imagine how
`
`
`
`
`11
`
`

`

`Industry Publications. Exhibits 2013, 2015, 2017, 2045, 2047, and 2055
`
`are various industry publications that provide evidence of the knowledge of a
`
`person of skill in the art during the relevant time and provide objective evidence of
`
`non-obviousness. Petitioners object to these exhibits as hearsay because specific
`
`quotes from these articles indicate, for example, open hole multi-stage fracturing
`
`was met with skepticism, Packers Plus is recognized as introducing this form of
`
`fracturing, Packers Plus’s reported results with the technology were surprising, etc.
`
`As an initial matter, these exhibits are offered as evidence of the state of mind or
`
`knowledge of a hypothetical person of ordinary skill in the art in 2001. None of
`
`the alleged hearsay statements purport to describe such a hypothetical person.
`
`Thus, Respondent is not relying on those statements for the truth of the matter.
`
`Stated differently, the fact that industry publications made these statements
`
`at all is admissible. Liberty Mutual Ins. Co., CBM2012-00010, Paper 59 at 37
`
`(overruling hearsay objection to industry publications because “[w]e have
`
`considered the statements therein not for the truth of the matter asserted, but for the
`
`fact that such statements were made at all.”); EMC Corp. v. Personal Web
`
`
`this type of market report could be prejudicial at all, especially since it is being
`presented to the Board rather than a jury. See SK Innovation Co., IPR2014-00680,
`Paper 57 at 28. Indeed, Petitioners do not even raise a Rule 403 objection, which
`sets a much lower bar for establishing prejudicial effect. For all of these reasons,
`this exhibit is admissible under Rule 807 as well.
`
`
`
`12
`
`

`

`Technologies, LLC, IPR2013-00085, Paper 73 at 66 (PTAB May 15, 2014); see
`
`also Fed. R. Evid. 801(c) 1997 Adv. Comm. Note (“If the significance of an
`
`offered statement lies solely in the fact that it was made, no issue is raised as to the
`
`truth of anything asserted, and the statement is not hearsay.”). Indeed, the
`
`evidence of industry skepticism is not merely that Mr. Casero said that the
`
`technology was met with skepticism (Ex. 2013), but rather, the fact that his article
`
`provides technical comparisons between plug and perf and open hole multi-stage
`
`fracturing is itself evidence of industry skepticism. Similarly, the fact that Packers
`
`Plus felt it necessary to justify the viability of the patented technology is evidence
`
`of skepticism and surprising results regardless of whether its articles actually use
`
`the phrases “skepticism” or “surprising” (Exs. 2015, 2017). And the fact that Mr.
`
`Britt treated Packers Plus’s StackFRAC system and Baker Hughes’s FracPoint
`
`system as similar in an industry publication is evidence of similarity (Ex. 2055).
`
`As to all of these exhibits, it is relevant that the cited statements were made at all.
`
`Moreover, as explained above with regard to the Ghiselin Study, even if the
`
`Board deems this exhibit inadmissible for any reason, they may still be considered
`
`under Rule 703. Mr. McGowen offered testimony based on these exhibits that has
`
`already been admitted. See Ex. 2081 at 25; Ex. 2051 at 46.
`
`Deposition and Trial Testimony. Petitioners object to the testimony of Ali
`
`Daneshy (Exs. 2016 and 2085) and a Baker Hughes corporate representative (Ex.
`
`
`
`13
`
`

`

`2097) as hearsay. However, prior deposition and trial testimony is not considered
`
`hearsay in IPRs. Petroleum Geo-Services Inc. v. WesternGeco LLC, IPR2014-
`
`01475, Paper 71 at 61 (PTAB July 11, 2016) (ruling prior deposition and trial
`
`testimony admissible for IPR purposes). In an inter partes review, direct testimony
`
`is typically provided via affidavit, with cross examination taken via deposition. 37
`
`C.F.R. § 42.53(a). In this respect, testimony via affidavit is considered in court
`
`testimony before the Board, in contrast to affidavit testimony in district court cases
`
`where it is considered out of court testimony. See Polaris Wireless, Inc. v.
`
`TruePosition, Inc., Case IPR2013-00323, slip op. at 41 (PTAB Nov. 3, 2014)
`
`(Paper 62). Testimony submitted via deposition or trial transcript is no different
`
`from testimony submitted in a written affidavit. Petroleum Geo-Services Inc.,
`
`IPR2014-01475, Paper 71 at 61. Petitioners had an opportunity to cross examine
`
`these witnesses by seeking to depose them in this proceeding. The fact that they
`
`chose not to do so does not render their testimony inadmissible. Id.
`
`Moreover, the testimony would be admissible as testimony from unavailable
`
`witnesses given that the witnesses are located more than 100 miles from
`
`Washington D.C. and because the Board typically does not allow live testimony.
`
`Fed. R. Ev. 804(b)(1); Fed. R. Civ. Proc. 32(a)(4)(B),(E). This testimony is also
`
`admissible under Rule 807. It is already admitted in the IPRs filed by
`
`Weatherford’s joint defense partner. Thus, it is trustworthy and evidence of
`
`
`
`14
`
`

`

`material facts. Moreover, given that these witnesses are incentivized to give
`
`testimony favorable to Weatherford, the fact that they did no do so is more
`
`probative than any other evidence Rapid Completions could reasonably obtain.
`
`Finally, admitting these exhibits serves the interests of justice by preventing
`
`inconsistent rulings on the same patents being challenged by joint defense partners.
`
`Packers Plus and Baker Hughes Design Drawings and Videos. Exhibits
`
`2018-2019 and 2052-2053, 2058-2059 are drawings, technical documents, and
`
`videos that illustrate the operation of Baker Hughes’ FracPoint system and Packers
`
`Plus’s StackFRAC system. The Packers Plus employees Tess McLeod and Ken
`
`Paltzat testified to the accuracy of several of these documents or their status as
`
`business records, thus, they are not hearsay. Ex. 2091, 2101. They are also
`
`admissible for the non-hearsay purpose of showing similarities between the two
`
`systems. For example, Rapid Completions need not rely on the truth of a statement
`
`in these documents to show that Baker Hughes’ technical design documents
`
`included a Packers Plus design drawing. For example, Weatherford identifies no
`
`“statement” in the design drawings that is being asserted for the truth of the matter.
`
`Rather, the Baker Hughes drawing is relevant because it is a modified Packers Plus
`
`drawing that found in the possession of Baker Hughes. See, e.g., Ex. 2082 at ¶¶
`
`12, 13. This evidence is also admissible under Rule 703 as Weatherford has not
`
`objected to Mr. McGowen’s analysis. Ex. 2081 at 27-30; Ex. 2051 at 46, 64-93.
`
`
`
`15
`
`

`

`Dated: October 12, 2017
`
`
`
`
`
`Respectfully submitted,
`
`Rapid Completions LLC
`
`By /Justin T. Nemunaitis/
`
`Hamad M. Hamad, Reg. No. 64,641
`Bradley W. Caldwell (pro hac vice)
`Justin T. Nemunaitis (pro hac vice)
`CALDWELL CASSADY CURRY,
`P.C.
`2101 Cedar Springs Road, Suite 1000
`Dallas, Texas 75201
`Telephone: 214.888.4848
`Facsimile: 214.888.4849
`hhamad@caldwellcc.com
`bcaldwell@caldwellcc.com
`jnemunaitis@caldwellcc.com
`rapid@caldwellcc.com
`
`Dr. Gregory Gonsalves, Re. No.
`43,639
`GONSALVES LAW FIRM
`2216 Beacon Lane
`Falls Church, Virginia 22043
`Telephone: 571.419.7252
`gonsalves@gonsalveslawfirm.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`16
`
`

`

`CERTIFICATE OF SERVICE UNDER 37 C.F.R. § 42.6 (e)(4)
`
`The undersigned hereby certifies that the foregoing document was served
`
`via electronic mail, as previously consented to by Petitioner upon the following
`
`counsel of record:
`
`Jason Shapiro (Lead Counsel)
`Patrick Finnan (Back-up Counsel)
`EDELL,SHAPIRO & FINNAN,
`LLC
`js@usiplaw.com
`pjf@usiplaw.com
`epatent@usiplaw.com
`
`Date: October 12, 2017
`
`
`
`
`
`/Hamad M. Hamad/
`
`Hamad M. Hamad, Reg. No. 64,641
`
`17
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket